SPRY4-IT1 has been reported to have extremely high expression in normal placenta tissues. It is a Long noncoding RNA (lncRNA), which is associated with cell growth, migration, invasion, and apoptosis in melanoma. A 2.8-fold increase of SPRY4-IT1 expression was validated by Real-time reverse transcription-polymerase chain reaction (qRT-PCR) in severe preeclamptic placenta as compared with that of the normal ones (n=25) in this study. Furthermore, the role of SPRY4-IT1 in proliferation, migration, apoptosis, and network formation ability of trophoblast cells HTR-8/SVneo was assessed. Suppression of SPRY4-IT1 using siRNA treatment and its overexpression using plasmid targeting SPRY4-IT1 were performed in order to explore the biological function of SPRY4-IT1 in the development and progression of trophoblast cells HTR-8/SVneo, in vitro. The results showed that SPRY4-IT1 knockdown enhanced the cell migration and proliferation, and reduced the response of cells to apoptosis. However, exogenous SPRY4-IT1 overexpression significantly decreased the cell migration and proliferation, while increased cell apoptosis. Our study showed for the first time that aberrant expression of lncRNA SPRY4-IT1 might contribute to the abnormal condition of trophoblast cells HTR-8/SVneo. Therefore, we proposed SPRY4-IT1 as a novel lncRNA molecule, which might be associated with the pathogenesis of preeclampsia and might provide a new target for its early diagnosis and treatment.
References
[1]
Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-2869. doi:10.1161/CIRCULATIONAHA.109.853127. PubMed: 21690502.
[2]
Peter ST, Scholl TO, Schluter MD, Leskiw MJ, Chen X et al. (2008) Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res 42: 841-848. doi:10.1080/10715760802510069. PubMed: 18985484.
[3]
Sacks GP, Studena K, Sargent K, Redman CW (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 179: 80-86. doi:10.1016/S0002-9378(98)70254-6. PubMed: 9704769.
[4]
Saftlas AF, Beydoun H, Triche E (2005) Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 106: 162-172. doi:10.1097/01.AOG.0000167389.97019.37. PubMed: 15994633.
[5]
Conrad KP, Benyo DF (1997) Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37: 240-249. doi:10.1111/j.1600-0897.1997.tb00222.x. PubMed: 9127646.
[6]
Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA (2001) Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722. doi:10.1161/01.HYP.38.3.718. PubMed: 11566964.
[7]
Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA et al. (2007) Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50: 137-142. doi:10.1161/HYPERTENSIONAHA.107.087700. PubMed: 17515455.
[8]
Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46: 1077-1085. doi:10.1161/01.HYP.0000187899.34379.b0. PubMed: 16230516.
[9]
Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A et al. (2004) L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43: 614-622. doi:10.1161/01.HYP.0000116220.39793.c9. PubMed: 14744923.
[10]
Walsh SW (1998) Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 16: 93-104. doi:10.1055/s-2007-1016256. PubMed: 9654611.
[11]
Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R (2002) Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol 187: 735-740. doi:10.1067/mob.2002.126283. PubMed: 12237656.
[12]
Burton GJ, Yung HW (2011) Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia. Pregnancy Hypertens 1: 72-78. PubMed: 22242213.
[13]
Heazell AE, Buttle HR, Baker PN, Crocker IP (2008) Altered expression of regulators of caspase activity within trophoblast of normal pregnancies and pregnancies complicated by preeclampsia. Reprod Sci 15: 1034-1043. doi:10.1177/1933719108322438. PubMed: 19088373.
Pijnenborg R, Vercruysse L, Hanssens M (2006) The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27: 939-958. doi:10.1016/j.placenta.2005.12.006. PubMed: 16490251.
[16]
Basak S, Duttaroy AK (2013) Effects of fatty acids on angiogenic activity in the placental extravillious trophoblast cells. Prostaglandins Leukot Essent Fatty Acids 88: 155-162. doi:10.1016/j.plefa.2012.10.001. PubMed: 23153451.
[17]
Waddell JM, Evans J, Jabbour HN, Denison FC (2011) CTGF expression is up-regulated by PROK1 in early pregnancy and influences HTR-8/Svneo cell adhesion and network formation. Hum Reprod 26: 67-75. doi:10.1093/humrep/26.s1.46. PubMed: 21098624.
[18]
Dokras A, Gardner LM, Seftor EA, Hendrix MJ (2001) Regulation of human cytotrophoblast morphogenesis by hepatocyte growth factor/scatter factor. Biol Reprod 65: 1278-1288. doi:10.1095/biolreprod65.4.1278. PubMed: 11566754.
[19]
Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA et al. (2011) The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res 71: 3852-3862. doi:10.1158/1538-7445.AM2011-3852. PubMed: 21558391.
[20]
Gibb EA, Brown CJ, Lam WL (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38. doi:10.1158/1535-7163.TARG-11-C38. PubMed: 21489289.
[21]
Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J et al. (2013) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32: 1616-1625. doi:10.1038/onc.2012.193. PubMed: 22614017.
[22]
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076. doi:10.1038/nature08975. PubMed: 20393566.
[23]
Braconi C, Kogure T, Valeri N, Huang N, Nuovo G et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750-4756. doi:10.1038/onc.2011.193. PubMed: 21625215.
[24]
Eissmann M, Gutschner T, H？mmerle M, Günther S, Caudron-Herger M et al. (2012) Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 9: 1076-1087. doi:10.4161/rna.21089. PubMed: 22858678.
[25]
Kitroser E, Pomeranz M, Epstein SG, Fishman A, Drucker L et al. (2012) The involvement of eukaryotic translation initiation factor 4E in extravillous trophoblast cell function. Placenta 33: 717-724. doi:10.1016/j.placenta.2012.06.004. PubMed: 22748716.
[26]
Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS et al. (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206: 204-211. doi:10.1006/excr.1993.1139. PubMed: 7684692.
[27]
Liu S, Li Q, Na Q, Liu C (2012) Endothelin-1 stimulates human trophoblast cell migration through Cdc42 activation. Placenta 33: 712-716. doi:10.1016/j.placenta.2012.06.010. PubMed: 22770822.
[28]
Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC et al. (2005) The transcriptional landscape of the mammalian genome. Science 309: 1559-1563. doi:10.1126/science.1112014. PubMed: 16141072.
[29]
Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S et al. (2005) Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308: 1149-1154. doi:10.1126/science.1108625. PubMed: 15790807.
[30]
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY et al. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250. doi:10.1245/s10434-011-1581-y. PubMed: 21327457.
[31]
Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M et al. (1991) A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349: 38-44. doi:10.1038/349038a0. PubMed: 1985261.
[32]
Brown CJ, Hendrich BD, Rupert JL, Lafrenière RG, Xing Y et al. (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71: 527-542. doi:10.1016/0092-8674(92)90520-M. PubMed: 1423611.
[33]
Koerner MV, Pauler FM, Huang R, Barlow DP (2009) The function of non-coding RNAs in genomic imprinting. Development 136: 1771-1783. doi:10.1242/dev.030403. PubMed: 19429783.
[34]
Payer B, Lee JT (2008) X chromosome dosage compensation: how mammals keep the balance. Annu Rev Genet 42: 733-772. doi:10.1146/annurev.genet.42.110807.091711. PubMed: 18729722.
[35]
Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914. doi:10.1016/j.molcel.2011.08.018. PubMed: 21925379.
[36]
Cui Z, Ren S, Lu J, Wang F, Xu W et al. (2013) The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol 31: 1117-1123. doi:10.1016/j.urolonc.2011.11.030. PubMed: 22264502.
[37]
Hu W, Yuan B, Flygare J, Lodish HF (2011) Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev 25: 2573-2578. doi:10.1101/gad.178780.111. PubMed: 22155924.
[38]
Mattick JS (2009) The genetic signatures of noncoding RNAs. PLOS Genet 5: e1000459. PubMed: 19390609.
[39]
Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R et al. (2007) The H19 non-coding RNA is essential for human tumor growth. PLOS ONE 2: e845. doi:10.1371/journal.pone.0000845. PubMed: 17786216.
[40]
Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693. doi:10.1126/science.1192002. PubMed: 20616235.
[41]
Dewing AS, Rueli RH, Robles MJ, Nguyen-Wu ED, Zeyda T et al. (2012) Expression and regulation of mouse selenoprotein P transcript variants differing in non-coding RNA. RNA Biol 9: 1361-1369. doi:10.4161/rna.22290. PubMed: 23064117.
[42]
Qu Z, Adelson DL (2012) Identification and comparative analysis of ncRNAs in human, mouse and zebrafish indicate a conserved role in regulation of genes expressed in brain. PLOS ONE 7: e52275. doi:10.1371/journal.pone.0052275. PubMed: 23284966.
[43]
Khalil AM, Rinn JL (2011) RNA-protein interactions in human health and disease. Semin Cell Dev Biol 22: 359-365. doi:10.1016/j.semcdb.2011.02.016. PubMed: 21333748.
Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O et al. (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369. doi:10.1016/j.cell.2011.09.028. PubMed: 22000014.
[46]
Khalil AM, Guttman M, Huarte M, Garber M, Raj A et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106: 11667-11672. doi:10.1073/pnas.0904715106. PubMed: 19571010.
[47]
Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ et al. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419. doi:10.1016/j.cell.2010.06.040. PubMed: 20673990.
[48]
Yu L, Chen M, Zhao D, Yi P, Lu L et al. (2009) The H19 gene imprinting in normal pregnancy and pre-eclampsia. Placenta 30: 443-447. doi:10.1016/j.placenta.2009.02.011. PubMed: 19342096.
